Morphine epigenomically regulates behavior through alterations in histone H3 lysine 9 dimethylation in the nucleus accumbens

Journal of Neuroscience

Volumn 32, Issue 48, 2012, Pages 17454-17464

  Sun, HaoSheng ^a   Maze, Ian ^b   Dietz, David M ^c   Scobie, Kimberly N ^a   Kennedy, Pamela J ^a   Damez Werno, Diane ^a   Neve, Rachael L ^d   Zachariou, Venetia ^a   Shen, Li ^a   Nestler, Eric J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; HISTONE DEMETHYLASE; HISTONE H3; HISTONE LYSINE METHYLTRANSFERASE; LYSINE; MORPHINE; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CHROMATIN IMMUNOPRECIPITATION; CONDITIONING; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MOUSE; MUTAGENESIS; NERVE CELL PLASTICITY; NICK END LABELING; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REWARD; RNA SEQUENCE; SENSITIZATION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ANIMALS; BEHAVIOR, ANIMAL; DNA METHYLATION; EPIGENESIS, GENETIC; GENE TRANSFER TECHNIQUES; HISTONES; MALE; MICE; MICE, INBRED C57BL; MORPHINE; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NUCLEUS ACCUMBENS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84870212393     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1357-12.2012     Document Type: Article

References (53)

1. Alló M, Schor IE, Munõz MJ, de la Mata M, Agirre E, Valcarcel J, Eyras E, Kornblihtt AR (2010) Chromatin and alternative splicing. Cold Spring Harb Symp Quant Biol 75:103-111.
2. Ambrosini A, Bresciani L, Fracchia S, Brunello N, Racagni G (1995) Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro. Mol Pharmacol 47:1057-1064.
3. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K (2007) High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837.
4. Bespalov AY, Zvartau EE (1996) Intraaccumbens administration of NMDA receptor antagonist ()-CPP prevents locomotor activation conditioned by morphine and amphetamine in rats. Pharmacol Biochem Behav 55:203-207.
5. Calvino B, Lagowska J, Ben-Ari Y (1979) Morphine withdrawal syndrome: differential participation of structures located within the amygdaloid complex and striatum of the rat. Brain Res 177:19-34.
6. Casimiro TM, Sossa KG, Uzunova G, Beattie JB, Marsden KC, Carroll RC (2011) mGluR and NMDAR activation internalize distinct populations of AMPARs. Mol CellNeurosci 48:161-170.
7. Covington HE 3rd, Maze I, Sun H, Bomze HM, DeMaio KD, Wu EY, Dietz DM, Lobo MK, Ghose S, Mouzon E, Neve RL, Tamminga CA, Nestler EJ (2011) A role for repressive histone methylation in cocaine-induced vulnerability to stress. Neuron 71:656-670.
8. Day JJ, Sweatt JD (2011) Epigenetic mechanisms in cognition. Neuron 70: 813-829.
9. Filion GJ, van Steensel B (2010) Reassessing the abundance of H3K9me2 chromatin domains in embryonic stem cells.Nat Genet 42:4; author reply 5-6.
10. Fritsch L, Robin P, Mathieu JR, Souidi M, Hinaux H, Rougeulle C, Harel-Bellan A, Ameyar-Zazoua M, Ait-Si-Ali S (2010) A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Mol Cell 37:46-56.
11. Guidotti A, Auta J, Chen Y, Davis JM, Dong E, Gavin DP, Grayson DR, Matrisciano F, Pinna G, Satta R, Sharma RP, Tremolizzo L, Tueting P (2011) Epigenetic GABAergic targetsin schizophrenia and bipolar disorder. Neuropharmacology 60:1007-1016.
12. Han MH, Renthal W, Ring RH, Rahman Z, Psifogeorgou K, Howland D, Birnbaum S, Young K, Neve R, Nestler EJ, Zachariou V (2010) Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia. Biol Psychiatry 67:761-769.
13. Hu JY, Jin GZ (2000) Arcuate nucleus of hypothalamus involved in analgesic action of l-THP. Acta Pharmacol Sin 21:439-444.
14. Inoue M, Mishina M, Ueda H (2003) Locus-specific rescue of GluRepsilon1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J Neurosci 23:6529-6536.
15. Ji D, Sui ZY, Ma YY, Luo F, Cui CL, Han JS (2004) NMDA receptor in nucleus accumbens is implicated in morphine withdrawal in rats. Neuro-chem Res 29:2113-2120.
16. Jing L, Luo J, Zhang M, Qin WJ, Li YL, Liu Q, Wang YT, Lawrence AJ, Liang JH (2011) Effect of the histone deacetylase inhibitors on behavioural sensitization to a single morphine exposure in mice. Neurosci Lett 494: 169-173.
17. Kaplan GB, Leite-Morris KA, Fan W, Young AJ, Guy MD (2011) Opiate sensitization induces FosB/DeltaFosB expression in prefrontal cortical, striatal and amygdala brain regions. PLoS One 6:e23574.
18. Koob GF, Maldonado R, Stinus L (1992) Neural substrates of opiate withdrawal. Trends Neurosci 15:186-191.
19. Kotlinska J, Bochenski M (2007) Comparison of the effects of mGluR1 and mGluR5 antagonists on the expression of behavioral sensitization to the locomotor effect of morphine and the morphine withdrawal jumping in mice. Eur J Pharmacol 558:113-118.
20. Kozela E, Pilc A, Popik P (2003) Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacol-ogy (Berl) 165:245-251.
21. Lea PM, Custer SJ, Vicini S, Faden AI (2002) Neuronal and glial mGluR5 modulation prevents stretch-induced enhancement of NMDA receptor current. Pharmacol Biochem Behav 73:287-298.
22. Lienert F, Mohn F, Tiwari VK, Baubec T, Roloff TC, Gaidatzis D, Stadler MB, Schübeler D (2011) Genomic prevalence of heterochromatic H3K9me2 and transcription do not discriminate pluripotent from terminally differentiated cells. PLoS Genet 7:e1002090.
23. Martin G, Ahmed SH, Blank T, Spiess J, Koob GF, Siggins GR (1999) Chronic morphine treatment alters NMDA receptor-mediated synaptic transmission in the nucleus accumbens. J Neurosci 19:9081-9089.
24. Martin G, Guadanõ-Ferraz A, Morte B, Ahmed S, Koob GF, De Lecea L, Siggins GR (2004) Chronic morphine treatment alters N-methyl-D-aspartate receptors in freshly isolated neurons from nucleus accumbens. J Pharmacol Exp Ther 311:265-273.
25. Maze I, Nestler EJ (2011) The epigenetic landscape of addiction. Ann N Y Acad Sci 1216:99-113.
26. Maze I, Covington HE 3rd, Dietz DM, LaPlant Q, Renthal W, Russo SJ, Mechanic M, Mouzon E, Neve RL, Haggarty SJ, Ren Y, Sampath SC, Hurd YL, Greengard P, Tarakhovsky A, Schaefer A, Nestler EJ (2010) Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 327:213-216.
27. Maze I, Feng J, Wilkinson MB, Sun H, Shen L, Nestler EJ (2011) Cocaine dynamically regulates heterochromatin and repetitive element unsilenc-ing in nucleus accumbens. Proc Natl Acad Sci USA 108:3035-3040.
28. Muotri AR, Zhao C, Marchetto MC, Gage FH (2009) Environmental influence on L1 retrotransposons in the adult hippocampus. Hippocampus 19:1002-1007.
29. Murray F, Harrison NJ, Grimwood S, Bristow LJ, Hutson PH (2007) Nucleus accumbens NMDA receptor subunit expression and function is enhanced in morphine-dependent rats. Eur J Pharmacol 562:191-197.
30. Noda Y, Nabeshima T (2004) Opiate physical dependence andN-methyl-D-aspartate receptors. Eur J Pharmacol 500:121-128.
31. Nye HE, Nestler EJ (1996) Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol Pharmacol 49: 636-645.
32. Peter CJ, Akbarian S (2011) Balancing histone methylation activities in psychiatric disorders. Trends Mol Med 17:372-379.
33. Popik P, Wróbel M (2002) Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Neuropharmacology 43:1210-1217.
34. Psifogeorgou K, Terzi D, Papachatzaki MM, Varidaki A, Ferguson D, Gold SJ, Zachariou V (2011) A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia. J Neurosci 31:5617-5624.
35. Pulvirenti L, Swerdlow NR, Koob GF (1991) Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine. Pharmacol Biochem Behav 40: 841-845.
36. Rehni AK, Singh N, Rachamalla M, Tikoo K (2012) Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome. Naunyn Schmiedebergs Arch Pharmacol 385:605-619.
37. Robison AJ, Nestler EJ (2011) Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12:623-637.
38. Rosenfeld JA, Wang Z, Schones DE, Zhao K, DeSalle R, Zhang MQ (2009) Determination of enriched histone modifications in non-genic portions of the human genome. BMC Genomics 10:143.
39. Sanchis-Segura C, Lopez-Atalaya JP, Barco A (2009) Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition. Neuropsychopharmacology 34: 2642-2654.
40. Sheng J, Lv Z, Wang L, Zhou Y, Hui B (2011) Histone H3 phosphoacetyla-tion is critical for heroin-induced place preference. Neuroreport 22: 575-580.
41. Shinkai Y, Tachibana M (2011) H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev 25:781-788.
42. Siggins GR, Martin G, Roberto M, Nie Z, Madamba S, De Lecea L (2003) Glutamatergic transmission in opiate and alcohol dependence. Ann N Y Acad Sci 1003:196-211.
43. Singer T, McConnell MJ, Marchetto MC, Coufal NG, Gage FH (2010) LINE-1 retrotransposons: mediators of somatic variation in neuronal genomes? Trends Neurosci 33:345-354.
44. Sun H, Kennedy PJ, Nestler EJ (2012) Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology. Advance online publication. Retrieved November 4, 2012. doi:10.1038/ npp.2012.73.
45. Trapnell C, Pachter L, Salzberg SL (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105-1111.
46. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28:511-515.
47. Vanderschuren LJ, Kalivas PW (2000) Alterations in dopaminergic and glu-tamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 151:99-120.
48. Wang R, Zhang Y, Qing H, Liu M, Yang P (2010) The extinction of morphine-induced conditioned place preference by histone deacetylase inhibition. Neurosci Lett 483:137-142.
49. Wen B, Wu H, Shinkai Y, Irizarry RA, Feinberg AP (2009) Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat Genet 41:246-250.
50. Wu Y, Li Y, Gao J, Sui N (2012) Differential effect of NMDA receptor antagonist in the nucleus accumbens on reconsolidation of morphine-related positive and aversive memory in rats. Eur J Pharmacol 674: 321-326.
51. Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, Berton O, Neve RL, Sim-Selley LJ, Selley DE, Gold SJ, Nestler EJ (2003) Essential role for RGS9 in opiate action. Proc Natl Acad Sci USA 100: 13656-13661.
52. Zachariou V, Bolanos CA, Selley DE, Theobald D, Cassidy MP, Kelz MB, Shaw-Lutchman T, Berton O, Sim-Selley LJ, Dileone RJ, Kumar A, Nes-tler EJ (2006) An essential role for DeltaFosB in the nucleus accumbens in morphine action. Nat Neurosci 9:205-211.
53. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, Liu XS (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol 9: R137.